🇺🇸 FDA

Drug profile · INN

tafamidis

VYNDAMAX

FDA: approved EMA: approved TGA: approved N07XX08
US status
approved
Patents linked
0
News articles
0

Quick answer

tafamidis (VYNDAMAX) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN tafamidis
Brand VYNDAMAX
Route ORAL
Formulation CAPSULE
ATC code N07XX08
Originator Pfizer Australia Pty Ltd

Frequently asked questions

What is tafamidis?

tafamidis (VYNDAMAX) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for tafamidis?

VYNDAMAX is a marketed brand name for tafamidis. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of tafamidis?

tafamidis has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.